Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

PURPOSE: CA 19-9 is an important tumor marker in patients with pancreatic adenocarcinoma. A secondary end point of Radiation Therapy Oncology Group trial 9704 was prospective evaluation of the ability of postresectional CA 19-9 to predict survival. METHODS: CA 19-9 expression was analyzed as a dicho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Berger, Adam C., Garcia, Miguel, Hoffman, John P., Regine, William F., Abrams, Ross A., Safran, Howard, Konski, Andre, Benson, Alan B., MacDonald, John, Willett, Christopher G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2008
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2645109/
https://ncbi.nlm.nih.gov/pubmed/19029412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.6288
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados